Premium
Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor
Author(s) -
FUCHSYOUNG R.,
GLASEBROOK A. L.,
SHORT L. L.,
DRAPER M. W.,
RIPPY M. K.,
COLE H. W.,
MAGEE D. E.,
TERMINE J. D.,
BRYANT H. U.
Publication year - 1995
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.1995.tb31392.x
Subject(s) - raloxifene , library science , medicine , estrogen receptor , computer science , breast cancer , cancer